Erratum. Use of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Type 1 Diabetes and Rates of Diabetic Ketoacidosis. Diabetes Care 2020;43:90-97.
2020
To comply with a new (January 2020) legal interpretation of the Data Use Agreement between the U.S. Food and Drug Administration’s Sentinel Initiative and the Centers for Medicare & Medicaid Services, the authors have made changes to the presentation of data in this article and the online supplementary material …
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI